Inventor · disambiguated record
Deepti Rokkam
Also filed as: ROKKAM DEEPTI
18 granted patents·23 pending applications·20 citations·filing 2014–2025
90Inventor score
Top patents by PatentIndex Score
41 records- 0195US11873349B1Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 16, 2024·3 cites·6 claims
- 0294US12103954B2Heterodimeric Fc cytokines and uses thereofSYNTHEKINE INC·Filed 2024·Granted Oct 1, 2024·2 cites·15 claims
- 0393US11859001B2IL12RB1-Binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jan 2, 2024·2 cites·14 claims
- 0491US12077594B2IL2RG binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Sep 3, 2024·3 cites·22 claims
- 0588US12012457B1IL23R binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Jun 18, 2024·1 cites·42 claims
- 0687US12291572B2IL12 receptor synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Granted May 6, 2025·1 cites·12 claims
- 0787US12157773B2IL27RAlpha binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Dec 3, 2024·1 cites·53 claims
- 0886US12297281B2IL10RA binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted May 13, 2025·1 cites·16 claims
- 0980US9993566B2SEZ6 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2014·Granted Jun 12, 2018·4 cites·41 claims
- 1079US2025340656A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 1179US2025376528A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 1278US2024376217A1Il23r binding molecules and methods of useSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1375US12209132B2Compositions and methods related to IL27 receptor bindingSYNTHEKINE INC·Filed 2023·Granted Jan 28, 2025·0 cites·19 claims
- 1475US2025019453A1Il2rb/il2g synthetic cytokinesSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1575US2024166754A1Il12rb1-binding molecules and methods of useSYNTHEKINE INC·Filed 2023·Application pending·0 cites
- 1675US2025171548A1IL27RAlpha BINDING MOLECULES AND METHODS OF USESYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1775US2025163167A1Il10 receptor binding molecules and methods of useSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 1872US12139545B2IL10 receptor binding molecules and methods of useSYNTHEKINE INC·Filed 2023·Granted Nov 12, 2024·0 cites·15 claims
- 1971US12286482B2IL10RB binding molecules and encoding nucleic acidsSYNTHEKINE INC·Filed 2021·Granted Apr 29, 2025·0 cites·13 claims
- 2071US10189910B2Anti-DPEP3 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2016·Granted Jan 29, 2019·1 cites·38 claims
- 2171US9777071B2Anti-DPEP3 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2016·Granted Oct 3, 2017·1 cites·15 claims
- 2269US2024026014A1Compositions and methods related to receptor pairingsSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 2369US2025179198A1Compositions and methods related to il27 receptor bindingSYNTHEKINE INC·Filed 2024·Application pending·0 cites
- 2467US12018085B2Interferon-gamma R2 (IFNGR2) binding molecules comprising single-domain antibodies and method of use thereof to treat autoimmune and inflammatory diseasesSYNTHEKINE INC·Filed 2021·Granted Jun 25, 2024·0 cites·109 claims
- 2567US2025333521A1Il10rb binding molecules and encoding nucleic acidsSYNTHEKINE INC·Filed 2025·Application pending·0 cites
- 2663US2023272094A1Il2rb/il2rg synthetic cytokinesSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 2759US12448457B2GP130 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Oct 21, 2025·0 cites·20 claims
- 2859US2023279126A1Il23 receptor synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 2959US2023279125A1Il28ra binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3059US2023391891A1Il28a receptor binding synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3159US2025382382A1Orthogonal gpc3 chimeric antigen receptor t cellsSYNTHEKINE INC·Filed 2023·Application pending·0 cites
- 3259US2023365696A1Ifngr1 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3358US2025333520A1Compositions and methods related to il2 receptor bindingSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 3458US2023357414A1Il12rb2 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3556US12122839B2IFNGR binding synthetic cytokines and methods of useSYNTHEKINE INC·Filed 2021·Granted Oct 22, 2024·0 cites·14 claims
- 3656US2023357424A1Cd45 binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Application pending·0 cites
- 3755US12234291B2IL2RB binding molecules and methods of useSYNTHEKINE INC·Filed 2021·Granted Feb 25, 2025·0 cites·37 claims
- 3854US2025163162A1Compositions and methods related to receptor pairingSYNTHEKINE INC·Filed 2022·Application pending·0 cites
- 3949US2019022241A1Novel sez6 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2018·Application pending·0 cites
- 4037US2019127476A1Novel anti-tnfrsf21 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2017·Application pending·0 cites
- 4132US2017073430A1Novel anti-rnf43 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Deepti Rokkam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →